Medical therapy of supraesophageal gastroesophageal reflux disease Review uri icon

Overview

MeSH Major

  • Esophagitis
  • Gastroesophageal Reflux
  • Gastrointestinal Agents
  • Heartburn
  • Life Style

abstract

  • Medical therapy of supraesophageal gastroesophageal reflux disease (GERD) is based on the principals for treating patients with heartburn and erosive esophagitis, observations from the few available clinical trials, and clinical experience. In general, patients with supraesophageal GERD require higher doses of antireflux therapy, principally with proton pump inhibitors, for longer periods of time to effectively relieve symptoms compared with patients with heartburn and/or erosive esophagitis. This article reviews the current literature and discusses a suggested approach to medical management of these often complex patients.

publication date

  • March 6, 2000

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/S0002-9343(99)00359-9

PubMed ID

  • 10718472

Additional Document Info

start page

  • 170S

end page

  • 177S

volume

  • 108

number

  • 4 SUPPL. 1